Diagnostic and Prognostic Value of Cardiac Imaging in Amyloidosis

Loading...
Thumbnail Image

Identifiers

Publication date

Authors

Vidal-Pérez, Rafael
Vázquez-García, Raquel
Barge-Caballero, Gonzalo
Bouzas-Mosquera, Alberto
Soler, Rafaela
Larrañaga Moreira, José María
Vázquez Rodríguez, José Manuel

Advisors

Other responsabilities

Journal Title

Bibliographic citation

Vidal-Perez R, Vázquez-García R, Barge-Caballero G, Bouzas-Mosquera A, Soler-Fernandez R, Larrañaga-Moreira JM, Crespo-Leiro MG, Vazquez-Rodriguez JM. Diagnostic and prognostic value of cardiac imaging in amyloidosis. World J Cardiol 2020; 12(12): 599-614. URL: https://www.wjgnet.com/1949-8462/full/v12/i12/599.htm. DOI: https://dx.doi.org/10.4330/wjc.v12.i12.599

Type of academic work

Academic degree

Abstract

[Abstract] Amyloidosis is an infiltrative disease caused by extracellular protein deposition that has accumulated a lot of scientific production in recent years. Different types of amyloidosis can affect the heart. Transthyretin amyloidosis and light chain amyloidosis are the two most common types of cardiac amyloidosis. These entities have a poor prognosis, so accurate diagnostic techniques are imperative for determining an early therapeutic approach. Recent advances in cardiac imaging and diagnostic strategies show that these tools are safe and can avoid the use of invasive diagnostic techniques to histological confirmation, such as endomyocardial biopsy. We performed a review on the diagnostic and prognostic implications of different cardiac imaging techniques in cardiac amyloidosis. We mainly focus on reviewing echocardiography, cardiac magnetic resonance, computed tomography and nuclear imaging techniques and the different safety measurements that can be done with each of them.

Description

Rights

Atribución-NoComercial 4.0 Internacional
Atribución-NoComercial 4.0 Internacional

Except where otherwise noted, this item's license is described as Atribución-NoComercial 4.0 Internacional